Senthil K. Chinnakannan

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Unlocking cancer vaccine potential: What are the key factors?

Unlocking cancer vaccine potential: What are the key factors?

Journal: Human vaccines & immunotherapeutics

Published: April 02, 2024

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.

Journal: JHEP reports : innovation in hepatology

Published: March 10, 2023

NK cells limit therapeutic vaccine-induced CD8+T cell immunity in a PD-L1-dependent manner.

NK cells limit therapeutic vaccine-induced CD8+T cell immunity in a PD-L1-dependent manner.

Journal: Science translational medicine

Published: April 13, 2022

A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice.

A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice.

Journal: Hepatology (Baltimore, Md.)

Published: November 12, 2021

Adenovirus vectors activate Vδ2+ γδT cells in a type I interferon-, TNF-, and IL-18-dependent manner.

Adenovirus vectors activate Vδ2+ γδT cells in a type I interferon-, TNF-, and IL-18-dependent manner.

Journal: European journal of immunology

Published: May 14, 2021

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020.

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: October 23, 2020

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.

Journal: Nature communications

Published: October 02, 2020

Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel.

Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel.

Journal: Wellcome open research

Published: May 04, 2020

The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV.

The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV.

Journal: Vaccines

Published: March 02, 2020

Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes.

Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes.

Journal: Vaccine

Published: December 08, 2019

Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus.

Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus.

Journal: Hepatology (Baltimore, Md.)

Published: May 23, 2019

MAIT cell activation augments adenovirus vector vaccine immunogenicity.

MAIT cell activation augments adenovirus vector vaccine immunogenicity.

Journal: Science (New York, N.Y.)

Published: May 01, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026